π¬ bloomberg.com bloomberg.com
Novo's New US Chief on Lilly's Rival Weight-Loss Pill
Novo Nordisk Executive Vice President for US Operations Jamey Millar discusses the US approval of competitor Eli Lilly's obesity pill, the expansion of the GLP-1 category, and the rollout of a new subscription model. He talks with Katie Greifeld for "The Close." (Source: Bloomberg)
βhttps://www.bloomberg.com/news/videos/2026-04-01/novo-s-new-us-chief-on-lilly-s-rival-weight-loss-pill-video
Indexiert von findnix.eu Β· Eigene Seite einreichen